세계의 전임상 CRO 시장, 서비스별, 유형별, 동물 모델별, 모델 시스템별, 용도별, 최종사용자별, 지역별
Preclinical CRO Market, By Service, By Type, By Animal Model, By Model System, By Application, By End Users, By Geography
상품코드
:
1747286
리서치사
:
Coherent Market Insights
발행일
:
2025년 05월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
전임상 CRO 세계 시장 규모는 2025년에 67억 6,000만 달러, 2032년에는 122억 1,000만 달러에 이르고, 2025-2032년 CAGR 8.82%를 보일 것으로 예측됩니다.
| 보고서 범위 |
보고서 상세 |
| 기준 연도 |
2024 |
2025년 시장 규모 |
67억 6,000만 달러 |
| 실적 데이터 |
2020-2024년 |
예측 기간 |
2025-2032년 |
| 예측 기간(2025-2032년) CAGR |
8.82% |
2032년 가치 예측 |
122억 1,000만 달러 |
세계 전임상 CRO 시장은 제약사 및 생명공학 기업의 전임상 연구 활동 아웃소싱 수요 증가에 힘입어 최근 큰 폭으로 성장하고 있습니다. 전임상시험수탁기관(CRO)은 독성시험, 약동학 및 약력학 시험, 동물모델 개발 등 다양한 서비스를 제공하며, 신약개발 과정에서 중요한 역할을 담당하고 있습니다. 이들 조직은 의약품 개발의 전임상 단계를 간소화함으로써 제약사가 핵심 역량에 집중하고 새로운 치료법 시장 개척을 가속화할 수 있도록 돕고 있습니다. 전임상 CRO 시장은 경쟁이 치열하며, 여러 주요 기업들이 전 세계에 진출하여 고객의 진화하는 요구에 부응하기 위해 전문적인 서비스와 첨단 기술을 제공합니다. 제약업계가 R&D 비용 상승과 규제 당국의 강화된 감시와 같은 문제에 직면하면서 전임상 CRO 서비스에 대한 수요는 향후 몇 년 동안 더욱 확대될 것으로 예측됩니다.
시장 역학:
세계 전임상 CRO 시장은 제약 및 생명공학 기업의 전임상 연구 활동 아웃소싱 증가, 전문적인 전임상 서비스에 대한 수요 증가, 의약품 개발 비용 및 일정 단축의 필요성 등 여러 가지 요인에 의해 주도되고 있습니다. CRO에 전임상시험을 아웃소싱함으로써 기업은 막대한 자본 투자 없이도 전문 지식, 첨단 기술, 최첨단 시설을 이용할 수 있습니다. 또한, 의약품 개발의 복잡성과 엄격한 규제 요건을 준수해야 할 필요성은 전임상 CRO 서비스에 대한 수요를 더욱 증가시키고 있습니다. 그러나 높은 전임상시험 비용, 제한된 숙련된 전문가, 데이터 보안 및 지적 재산권 보호와 관련된 문제 등의 요인으로 인해 시장 성장이 제한될 수 있습니다. 이러한 과제에도 불구하고 전임상 CRO 시장은 3D 세포 배양, 장기 온칩, 인실리콘 모델링 등 전임상시험의 예측 가능성과 효율성 향상에 도움이 되는 첨단 기술의 채택이 증가함에 따라 큰 성장 기회를 보이고 있습니다. 또한, 개인 맞춤형 의료에 대한 수요 증가와 희귀질환 및 희귀의약품에 대한 관심 증가는 향후 몇 년 동안 전임상 CRO에 새로운 비즈니스 기회를 제공할 것으로 예측됩니다.
본 조사의 주요 특징
- 세계의 전임상 CRO 시장을 상세하게 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모와 CAGR을 조사하여 전해드립니다.
- 또한, 다양한 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 주요 고찰을 제공합니다.
- 이 보고서는 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략 등의 매개 변수를 기반으로 세계 전임상 CRO 시장의 주요 기업을 프로파일링합니다.
- 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 전임상 CRO 세계 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 전임상 CRO 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 발매/승인
- PEST 분석
- PORTER 분석
- 인수합병(M&A) 시나리오
- 업계 동향
제4장 세계의 전임상 CRO 시장, 서비스별, 2020년-2032년
- 생체 분석과 DMPK 연구
- 독성 시험
- 화합물 관리
- 화학
- 안전성 약리학
- 기타
제5장 세계의 전임상 CRO 시장, 유형별, 2020년-2032년
- 환자 유래 오가노이드(PDO) 모델
- 환자 유래 이종 이식(PDX) 모델
제6장 세계의 전임상 CRO 시장, 동물 모델별, 2020년-2032년
제7장 세계의 전임상 CRO 시장, 모델 시스템별, 2020년-2032년
제8장 세계의 전임상 CRO 시장, 용도별, 2020년-2032년
제9장 세계의 전임상 CRO 시장, 최종사용자별, 2020년-2032년
- 바이오의약품 기업
- 정부기관 및 학술기관
- 의료기기 기업
- 연구기관 및 대학
- 기타
제10장 세계의 전임상 CRO 시장, 지역별, 2020년-2032년
- 북미
- 라틴아메리카
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- 아프리카
제11장 경쟁 구도
- Charles River Laboratories
- Covance(Labcorp)
- WuXi AppTec
- ICON plc
- PPD(Part of Thermo Fisher Scientific)
- Medpace
- Evotec SE
- Syneos Health
- BioReliance(Merck KGaA)
- Charles River
- KCR
- Parexel International
- Inotiv
- Toxikon
- Harlan Laboratories
제12장 애널리스트 추천 사항
- 기회
- 애널리스트의 견해
- Coherent Opportunity Map
제13장 참고 문헌과 조사 방법
LSH
영문 목차
Global Preclinical CRO Market is estimated to be valued at USD 6.76 Bn in 2025 and is expected to reach USD 12.21 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.82% from 2025 to 2032.
| Report Coverage |
Report Details |
| Base Year: |
2024 |
Market Size in 2025: |
USD 6.76 Bn |
| Historical Data for: |
2020 To 2024 |
Forecast Period: |
2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: |
8.82% |
2032 Value Projection: |
USD 12.21 Bn |
The global preclinical CRO market has witnessed significant growth in recent years, driven by the increasing demand for outsourcing preclinical research activities by pharmaceutical and biotechnology companies. Preclinical Contract Research Organizations (CROs) play a crucial role in the drug discovery and development process, providing a wide range of services such as toxicology testing, pharmacokinetic and pharmacodynamic studies, and animal model development. These organizations help streamline the preclinical phase of drug development, enabling pharmaceutical companies to focus on their core competencies and accelerate the delivery of new therapies to the market. The preclinical CRO market is highly competitive, with several key players operating globally, offering specialized services and advanced technologies to meet the evolving needs of their clients. As the pharmaceutical industry continues to face challenges such as rising research and development costs and increasing regulatory scrutiny, the demand for preclinical CRO services is expected to grow further in the coming years.
Market Dynamics:
The global preclinical CRO market is driven by several factors, including the increasing outsourcing of preclinical research activities by pharmaceutical and biotechnology companies, the growing demand for specialized preclinical services, and the need to reduce drug development costs and timelines. Outsourcing preclinical studies to CROs allows companies to access specialized expertise, advanced technologies, and state-of-the-art facilities, without the need for significant capital investments. Additionally, the increasing complexity of drug development, coupled with the need to comply with stringent regulatory requirements, has further fueled the demand for preclinical CRO services. However, the market growth may be restrained by factors such as the high cost of preclinical studies, the limited availability of skilled professionals, and the challenges associated with data security and intellectual property protection. Despite these challenges, the preclinical CRO market presents significant opportunities for growth, driven by the increasing adoption of advanced technologies such as 3D cell culture, organ-on-a-chip, and in silico modeling, which can help improve the predictivity and efficiency of preclinical studies. Moreover, the growing demand for personalized medicine and the increasing focus on rare diseases and orphan drugs are expected to create new opportunities for preclinical CROs in the coming years.
Key Features of the Study:
- This report provides in-depth analysis of the global preclinical CRO market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global preclinical CRO market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Charles River Laboratories, Covance (Labcorp), WuXi AppTec, ICON plc, PPD (Part of Thermo Fisher Scientific), Medpace, Evotec SE, Syneos Health, BioReliance (Merck KGaA), Charles River, KCR, Parexel International, Inotiv, Toxikon, and Harlan Laboratories
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global preclinical CRO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preclinical CRO market
Market Segmentation
- Service Insights (Revenue, USD Bn, 2020 - 2032)
- Bioanalysis and DMPK studies
- In vitro ADME
- In-vivo PK
- Toxicology Testing
- GLP
- Non-GLP
- Compound Management
- Process R&D
- Custom Synthesis
- Others
- Chemistry
- Medicinal Chemistry
- Computation Chemistry
- Safety Pharmacology
- Others
- Type Insights (Revenue, USD Bn, 2020 - 2032)
- Patient-Derived Organoid (PDO) Models
- Patient-Derived Xenograft (PDX) Models
- Animal Model Insights (Revenue, USD Bn, 2020 - 2032)
- Small Animal Model
- Large Animal Model
- Model System Insights (Revenue, USD Bn, 2020 - 2032)
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Neurology
- Cardiology
- Infectious Diseases
- Metabolic Disorders
- Others
- End Users Insights (Revenue, USD Bn, 2020 - 2032)
- Biopharmaceutical Companies
- Government and Academic Institutes
- Medical Device Companies
- Research Institutes and Universities
- Others
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Charles River Laboratories
- Covance (Labcorp)
- WuXi AppTec
- ICON plc
- PPD (Part of Thermo Fisher Scientific)
- Medpace
- Evotec SE
- Syneos Health
- BioReliance (Merck KGaA)
- Charles River
- KCR
- Parexel International
- Inotiv
- Toxikon
- Harlan Laboratories
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Preclinical CRO Market, By Service
- Global Preclinical CRO Market, By Type
- Global Preclinical CRO Market, By Animal Model
- Global Preclinical CRO Market, By Model System
- Global Preclinical CRO Market, By Application
- Global Preclinical CRO Market, By End Users
- Global Preclinical CRO Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Preclinical CRO Market, By Service, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Bioanalysis and DMPK studies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Toxicology Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Compound Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Process R&D
- Custom Synthesis
- Others
- Chemistry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Medicinal Chemistry
- Computation Chemistry
- Safety Pharmacology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Preclinical CRO Market, By Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Patient-Derived Organoid (PDO) Models
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Patient-Derived Xenograft (PDX) Models
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Preclinical CRO Market, By Animal Model, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Small Animal Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Large Animal Model
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Preclinical CRO Market, By Model System, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- In Vivo
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- In Vitro
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Preclinical CRO Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cardiology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Metabolic Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Preclinical CRO Market, By End Users, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Government and Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Medical Device Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Research Institutes and Universities
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Preclinical CRO Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Model System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Latin America
- Introduction
- Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Model System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Model System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Model System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Model System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Animal Model, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Model System, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End Users, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Charles River Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Covance (Labcorp)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- WuXi AppTec
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- ICON plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PPD (Part of Thermo Fisher Scientific)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medpace
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Evotec SE
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Syneos Health
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BioReliance (Merck KGaA)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Charles River
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- KCR
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Parexel International
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Inotiv
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Toxikon
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Harlan Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
관련자료
